MICHAEL CELANO - Corporate Board Profile

ORASURE TECHNOLOGIES INC

Filing Date	Source Excerpt
2009-04-01	Michael Celano has served as Chief Financial Officer of Kensey Nash Corporation, a biomaterials company, and was a partner with KPMG LLP in charge of its Mid-Atlantic Life Sciences Practice. He is a Certified Public Accountant and holds a B.S. degree in Accounting.
2010-04-01	Mr. Celano is a Certified Public Accountant and holds a B.S. degree in Accounting from St. Joseph’s University.
2011-04-07	Mr. Celano’s accounting and financial expertise, and specifically his long career in public accounting focused in the life sciences area, and his extensive business experience led to the conclusion that he should serve on the Company’s Board.
2012-04-05	Mr. Celano is a Certified Public Accountant and holds a B.S. degree in Accounting from St. Joseph's University. Mr. Celano's accounting and financial expertise, and specifically his long career in public accounting focused in the life sciences area, and his extensive business experience led to the conclusion that he should serve on the Company's Board.
2013-04-04	Mr. Celano is a Certified Public Accountant and holds a B.S. degree in Accounting from St. Joseph’s University. Mr. Celano’s accounting and financial expertise, and specifically his long career in public accounting focused in the life sciences area, and his extensive business experience led to the conclusion that he should serve on the Company’s Board.
2014-04-11	Michael Celano Chief Financial Officer of Drugscan, Inc. ... Mr. Celano holds a B.S. degree in Accounting from St. Joseph's University.
2015-04-01	Michael Celano has served as Chief Financial Officer of DrugScan, Inc., a clinical laboratory services company, and has a long career in public accounting focused in the life sciences area.
2016-04-04	Long career in public accounting focused in the life sciences area, Accounting and financial expertise.
2017-04-05	Long career in public accounting focused in the life sciences area. Accounting and financial expertise.
2018-03-29	Mr. Celano holds a B.S. in Accounting from St. Joseph’s University.
2019-04-10	Mr. Celano holds a B.S. in Accounting from St. Joseph’s University. He has accounting and financial expertise and extensive business experience in the life sciences industry.
2020-04-09	Mr. Celano holds a B.S. in Accounting from St. Joseph’s University and has a long career in public accounting focused in the life sciences area.
2021-04-08	Michael Celano became a member of the Board in October 2006 and has served as the Company’s Chairman of the Board since April 2018. Mr. Celano has served as the Chief Financial Officer of Larimar Therapeutics since May 2020. Mr. Celano served as the Chief Operating Officer of Recro Pharma, Inc. between July 2016 and May 2019, Mr. Celano served as its Chief Financial Officer. Between 2015 and June 2016 Mr. Celano was self-employed providing consulting services to healthcare companies. Prior to that, Mr. Celano served as the Chief Financial Officer of Kensey Nash Corporation, a biomaterials company from 2009 to 2012. From 2007 to 2008, Mr. Celano also served as Chief Financial Officer for BioRexis Pharmaceutical Corporation, a biopharmaceutical company. Before joining BioRexis, Mr. Celano served as a partner with KPMG LLP, where he was co-leader of its National Life Science Practice. Mr. Celano also was co-leader of the Life Science Practice for Arthur Andersen before he joined KPMG. Mr. Celano holds a B.S. in Accounting from St. Joseph’s University.
2022-04-07	Mr. Celano has a long career in public accounting focused in the life sciences area, life sciences industry operating company experience, accounting and financial expertise, and extensive business experience. He holds a B.S. in Accounting.